Efficacy Study of SYN006 HFA MDI in Asthma Patients
NCT02162784
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Budesonide/Procaterol, 180/10mcg X1
DRUG:
Budesonide/procaterol 180/10 mcg X 2
DRUG:
Albuterol HFA MDI 100mcg X2
Sponsor
Intech Biopharm Ltd.